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Introduction
The leukemia/lymphoma-related factor (LRF) is a tran-
scription factor containing an N-terminal POZ (poxvirus 
and zinc finger) domain and a C-terminal zinc finger 
domain. LRF belongs to the POK (POZ and Krüppel) pro-
tein families that are important for cellular differentiation 
and tumorigenesis.1,2 LRF directly represses the transcrip-
tion of the tumor suppressor p19ARF, which in turn is 
required for p53 stability and function.3 Hence, aberrant 
overexpression of LRF is associated with some human can-
cers, such as lymphoma, glioma, breast, and non–small cell 
lung carcinomas.3,4 Ectopic overexpression of LRF in B and 
T lymphoid cells also causes aggressive lymphoma in 
mice.3 Apart from its oncogenic activity when overex-
pressed, normal expression of LRF is required to maintain 
cellular proliferation and prevent the induction of senes-
cence in mouse embryonic fibroblast.3,5
A high level of LRF is detected in chondroprogenitor 
cells at the developing mouse limb buds at 10.5 dpc prior to 
overt chondrogenesis,6 suggesting the involvement of LRF 
in skeletal development. In addition, we have shown that 
aberrant expression of LRF contributes to the development 
of chondrosarcoma and tumor malignancy.7 Depletion of 
LRF in chondrosarcoma cell lines dramatically reduces pro-
liferation and enhances their sensitivity to the anticancer 
drug doxorubicin. Furthermore, other evidences suggest a 
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Abstract
Objective. The oncogene leukemia/lymphoma-related factor (LRF) enhances chondrosarcoma proliferation and malignancy. 
This study aimed to investigate the roles of LRF in chondrogenic differentiation of primary human bone marrow–derived 
mesenchymal stem cells (BMSCs). Design. LRF was overexpressed in BMSC by lentiviral transduction. Chondrogenic 
differentiation of BMSC was induced by high-density pellet culture. Western blotting and real-time polymerase chain 
reaction were used to investigate changes in protein and mRNA levels, respectively, during chondrogenesis. Safranin-O 
staining, immunohistochemistry, and glycoaminoglycan contents were used to assess cartilage matrix deposition. BMSC 
proliferation was determined by mitochondrial dehydrogenase activity and cell counting. Cell cycle profiling was performed 
by flow cytometry. Results. LRF overexpression effectively inhibited protein and mRNA expression of chondrocyte markers 
and cartilage matrix deposition during chondrogenesis of BMSC. Endogenous LRF expression was constitutively high in 
undifferentiated BMSC but remained low in primary articular chondrocytes. Endogenous LRF protein was downregulated 
in a time-dependent manner during chondrogenesis. BMSCs overexpressing LRF had higher proliferation rates and cell 
population in the S phase. LRF suppressed p53 expression during chondrogenesis and this might prevent differentiating 
chondrocytes from entering a quiescent state. Conclusion. Our data showed that LRF is important for stimulating stem cell 
proliferation and cell cycle progression. It is known that LRF is highly expressed in the mouse limb buds prior to overt 
chondrogenesis; thus, LRF might function to prevent premature chondrogenic differentiation of stem cells.
Keywords
chondrogenesis, cells, mesenchymal stem cells, proliferation, chondrocytes, LRF
330 Cartilage 4(4)
direct role of LRF in chondrogenesis, as overexpression of 
LRF in the mouse mesenchymal stem cell line, C3H10T1/2, 
inhibits in vitro chondrogenesis.8 The inhibitory action of 
LRF on chondrogenesis is in part due to its direct binding 
and suppression of the cartilage oligomeric matrix protein 
(COMP) promoter, thus negating the positive effects of 
Sox9 on COMP gene expression.9 However, LRF also sup-
presses expression of other cartilage matrix genes, such as 
collagen type II, type X, and aggrecan, during chondrogen-
esis.8 This suggests that LRF may also function through a 
distinct mechanism to suppress the expression of other car-
tilage matrix genes to inhibit chondrogenesis.
Our objective is to investigate the functions of LRF in 
chondrogenesis of primary human mesenchymal stem cells. 
Here, we determined the effects of ectopic overexpression 
of LRF on chondrogenesis of human bone marrow–derived 
mesenchymal stem cells (BMSCs). We also examined the 
steady state and temporal expression of endogenous LRF 
during chondrogenic differentiation of primary BMSCs. 
We found that LRF inhibited chondrogenesis by stimulat-
ing proliferation of BMSCs and suppressing p53 expres-
sion, and thus preventing the maturing chondrocytes from 
entering a quiescent state.
Methods
Cell Culture
Human bone marrow aspirates and cartilage from patients 
undergoing total knee arthroplasty were obtained with insti-
tutional review board approval. Primary BMSCs were iso-
lated according to a previously described protocol.10 BMSC 
was maintained in MSCGM (mesenchymal stem cell 
growth medium) media (PT-3001 from Lonza, Basel 
Switzerland), supplemented with 1 ng/mL basic fibroblastic 
growth factor (Roche, Basel, Switzerland). BMSC between 
passages 2 and 6 were used for the experiments throughout 
this study (at least 2-3 different donors per experiment). 
Primary human articular chondrocytes were isolated as 
described,11 passage 0 chondrocytes were used for experi-
ments to minimize the loss of chondrocytic phenotype due 
to dedifferentiation and proliferation in culture. The immor-
talized human chondrocyte cell line C20/A4 (a generous 
gift from Dr. Mary Goldring at Harvard University), 
C3H10T1/2 cells (ATCC), and primary human articular 
chondrocytes were maintained in Dulbecco’s modified 
Eagle medium (high glucose) supplemented with 10% fetal 
bovine serum and 1% penicillin–streptomycin (all from 
Invitrogen, Carlsbad, CA).
Generation of Lentivirus
Human LRF cDNA (clone ID 8322563) was purchased 
(Open Biosystems, Huntsville, AL) and subcloned into a 
pCCL-based lentiviral vector12 with the addition of an 
N-terminal FLAG tag. A pCCL-based construct expressing 
green fluorescent protein (GFP) was also generated as con-
trol. Replication incompetent lentiviruses were packaged in 
293T cells as described.12 BMSCs grown in monolayer 
were infected with lentivirus at 10 multiplicity of infection 
with 1 µg/mL polybrene and the media was replaced 16 
hours later. Seventy-two hours after infection, BMSCs were 
used for in vitro chondrogenesis in pellet culture.
In Vitro Chondrogenesis
Primary human mesenchymal stem cells were isolated from 
discarded tissues obtained during total knee arthroplasty 
operations, with institutional review board approval and 
patient consent. Bone marrow was diluted 10 times in 
Hanks’s balanced salt solution, and nucleated cells stained 
with crystal violet and counted. Nucleated cells were plated 
onto tissue-culture treated plastic at a density of 10,000 
cells/cm2, in α-MEM (GIBCO, Carlsbad, CA) supple-
mented with 0.1 mM nonessential amino acids, 1 mM 
sodium pyruvate, 100 mM HEPES, 100 U/mL penicillin, 
100 mg/mL streptomycin, 29 mg/mL l-glutamine, 10% 
(v/v) fetal bovine serum (Lonza), and 5 ng/mL FGF-2 
(R&D Systems, Minneapolis, MN). For chondrogenic dif-
ferentiation in vitro, 4 x 104 cells were cultured in micro-
mass pellet cultures in polypropylene screw-cap tubes, with 
media changes every 3 days. Chondrogenic medium was 
Dulbecco’s modified Eagle medium (high glucose) with 
1% ITS+ (BD Biosciences, San Jose, CA), 100 nM dexa-
methasone (MP Biomedicals, Santa Ana, CA), 50 µg/mL 
ascorbic acid 2-phosphate (Sigma, St. Louis, MO), 40 µg/
mL Proline, 15mM HEPES, 10 ng/mL TGF-β1 (PeproTech, 
Rocky Hill, NJ), and 200 ng/mL rhBMP-2 (Medtronic, 
Minneapolis, MN).
Real-Time Reverse Transcriptase-Polymerase 
Chain Reaction
Total RNA from cells grown as pellet culture for various 
times were extracted using an RNeasy Mini Kit with DNase 
I digestion (both from Qiagen, Germantown, MD). The 
quantities and qualities of total RNA were assessed by a 
nanodrop instrument (Thermo Scientific, Waltham, MA), 
and 50 to 100 ng of RNA were reverse transcribed with ran-
dom hexamers using a Superscript first-strand kit (Invitrogen). 
Quantitative real-time polymerase chain reaction was per-
formed as triplicate measurements with the 7900HT qPCR 
instrument according to the manufacturer’s instructions 
(Applied Biosystems, Foster City, CA). The TaqMan Gene 
Expression Assays used are as follows: COL2A1 
Hs01060345_m1, COMP Hs00164359_m1, COL10A1 
Hs00166657_m1. The level of each target gene was normal-
ized to 18s rRNA and expressed as fold-change relative to the 
levels at time 0 (C
T
 method; Applied Biosystems).
Yik et al. 331
Western Blot Analysis
BMSCs in monolayer or pellet cultures, and primary articu-
lar chondrocytes (passage 1) were harvested and lysed with 
sample loading buffer (50 mM Tris–HCl, pH 6.8; 100 mM 
dithiothreitol; 4% 2-mercaptoethanol; 2% sodium dodecyl 
sulfate [SDS]; 10% glycerol). Lysates were resolved by 8% 
SDS-polyacrylamide gels and transferred onto nitrocellu-
lose membranes (BioRad, Hercules, CA). The membranes 
were blocked with 2% bovine serum albumin in TBST (25 
mM Tris–HCl, pH 7.5; 125 mM NaCl; 0.1% Tween 20), 
followed by incubation with rabbit polyclonal antiserum 
specific for human COMP,8 rabbit anti-LRF,7 mouse anti-
p53 (Santa Cruz Biotechnology, Santa Cruz, CA), and 
mouse anti-GAPDH (Ambion, Carlsbad, CA) at 4 °C over-
night. Blots were then probed with horseradish peroxidase-
conjugated secondary antibody (Santa Cruz Biotechnology), 
and reactive protein bands were visualized with Western 
Lightning Plus-ECL (PerkinElmer, Waltham, MA).
Safranin-O Staining
Twenty-one-day-old BMSC pellet cultures were fixed in 
10% formalin overnight and embedded in paraffin. Three-
micrometer sections mounted on glass slides were stained 
with Safranin-O and counterstained with hematoxylin as 
described.13
Immunohistochemistry
Sections of paraffin-embedded BMSC pellets were pro-
cessed for immunohistochemistry using mouse anti-human 
collagen type II (MP Biomedical clone II-4C11), and then 
visualized with ImmPRESS anti-mouse Ig reagent and 
ImmPACT NovaRED peroxidase substrate (Vector 
Laboratories, Burlingame, CA). Negative controls included 
an irrelevant primary antibody and omission of the second-
ary antibody.
DMMB Assays
Proteoglycan content of the cell pellets was determined 
using DMMB (dimethylmethylene blue). Briefly, pellets 
were digested overnight in proteinase K, DMMB dye 
(Sigma) was bound, and absorbance at 525 nm was mea-
sured and compared with that of chondroitin sulfate 
standards.
Cell Proliferation Assay
BMSCs were infected with GFP- or LRF-expressing lenti-
virus as described above and used at 4-day post-infection. 
For proliferation assays, 1 x 103 BMSCs were seeded in 
96-well plates with 100 µL media. At various days, the 
activities of mitochondrial dehydrogenase from live cells 
were determined by adding 1 µL of water-soluble tetrazo-
lium substrate (Quick Cell Proliferation Kit, BioVision, 
Milpitas, CA) and the optical density was measured at 440 
nm with a spectrophotometer after 2 hours. An empty 
96-well with 100 µL media was used as blank. For the 
determination of cell number, 10 x 103 BMSCs were seeded 
in 12-well plates (as day 0), and the numbers of cells were 
counted in a hemocytometer at days 2, 4, and 6.
Cell Cycle Profiling
Approximately 1 x 106 uninfected, GFP- or LRF-transduced 
BMSCs were harvested by trypsinization at 9 day post-
transduction. After centrifugation (500 x g, 5 minutes), the 
cell pellets were washed with phosphate-buffered saline 
and fixed with cold 70% ethanol for 30 minutes on ice. 
Cells were washed and resuspended in phosphate-buffered 
saline containing RNase (200 µg/mL) and incubated at 37 
°C for 30 minutes. Propidium iodide was added to a final 
concentration of 25 µg/mL and cells were incubated on ice 
for 30 minutes before acquiring by flow cytometry (FACS 
Fortessa LSR, Becton Dickinson, Franklin Lakes, NJ). The 
data were analyzed by FlowJo software.
Statistical Analysis
JMP software (version 8.0; SAS Institute, Cary, NC) was 
used for data analyses. The mRNA expression, growth 
rates, and cell cycle distribution profiles of LRF-infected 
BMSCs were compared to that of the uninfected and GFP-
infected BMSCs (unpaired Student’s t test, P < 0.05 is con-
sidered significant).
Results
LRF Inhibits Expression of Chondrocyte Markers 
during Chondrogenesis of BMSC
Our previous studies showed that LRF depletion reduces 
proliferation in chondrosarcoma cell lines, whereas ectopic 
overexpression of LRF in the mouse mesenchymal stem 
cell line C3H10T1/2 inhibited in vitro chondrogenesis. To 
gain more insight into the mechanism that regulates LRF’s 
function during chondrogenesis, we examined the effects of 
LRF overexpression on chondrogenesis of primary human 
BMSC in pellet culture. Lentivirus harboring human LRF, 
or GFP as a control, was used to transduce BMSC and 
chondrogenesis was induced by pellet culture. The mRNA 
levels of 2 chondrocyte markers, COMP and Col2a1, and 
the hypertrophic marker Col10, were monitored by quanti-
tative polymerase chain reaction in a 21-day time course. 
The data showed that uninfected or GFP-infected BMSCs 
produced increasing amounts of COMP, Col2a1, and Col10 
in a time-dependent manner during chondrogenesis as 
expected (Fig. 1). In contrast, LRF overexpression 
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significantly reduced Col2a1 mRNA expression during 
chondrogenesis. COMP and Col10 expression were also 
lowered in LRF-expressing BMSC, compared to control 
and GFP-infected BMSCs, although not achieving statisti-
cal significant (Fig. 1). Similar results were also obtained in 
pellet cultures of primary chondrocytes overexpressing 
LRF (data not shown), demonstrating a negative role of 
LRF in cartilage matrix gene expression.
LRF Inhibits Chondrogenesis of Primary Human 
BMSC
Next, the pellet cultures from uninfected and LRF-infected 
BMSCs at day 21 were stained with Safranin-O to assess 
proteoglycan deposition. The results showed that proteo-
glycan staining of the pellet culture overexpressing LRF is 
markedly reduced when compared with uninfected control 
(Fig. 2A, top panels). In addition, consistent with the 
mRNA results, Col2a1 protein was markedly reduced in 
LRF-expressing pellets (Fig. 2A, bottom panels). Western 
analysis showed that the production of COMP protein was 
greatly reduced in LRF-infected pellet culture when com-
pared to control (Fig. 2B). Thus, the protein expression pro-
files of COMP correlated well with the mRNA levels of 
COMP (Fig. 1) during chondrogenesis of BMSC. Similar 
results were obtained using BMSC from 2 other donors (not 
shown). Western analysis also demonstrated that the lenti-
viral expression system used in this study is effective in 
maintaining the long-term expression of LRF protein at 
least through day 14 of pellet culture.
We next examined the effects of LRF overexpression on 
the size and glycoaminoglycan (GAG) content of the pellet 
cultures. As shown in Figure 3A, the physical dimension of 
the pellets expressing LRF at various days was markedly 
reduced, compared with control and GFP-expressing pellets. 
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Figure 1. Leukemia/lymphoma-related factor (LRF) inhibits expression of cartilage matrix genes during chondrogenesis. Human 
bone marrow–derived mesenchymal stem cells (BMSCs) infected with lentivirus expressing LRF or green fluorescent protein (GFP) 
were induced to differentiate by pellet culture in chondrogenic media. The expression of cartilage markers cartilage oligomeric matrix 
protein (COMP) and Col2a1 mRNA, and the hypertrophic marker Col10, at the indicated time was determined by quantitative 
polymerase chain reaction in triplicates and normalized to 18s rRNA. The values shown for each gene at a given time points were 
fold-induction relative to un-induced BMSC at day 0. Results with standard deviation were averages of BMSC collected from 3 
different donors (*P < 0.05).
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Figure 2. Leukemia/lymphoma-related factor (LRF) 
inhibits proteoglycans production and cartilage oligomeric 
matrix protein (COMP), Col2a1 protein synthesis during 
chondrogenesis of BMSC. (A) LRF inhibits proteoglycans and 
Col2a1 deposition. Day 21 pellet cultures of uninfected and 
LRF-infected human bone marrow–derived mesenchymal stem 
cells (BMSCs) were sectioned and stained with Safranin-O/
hematocylin (upper panels) and anti-Col2a1 antibody to reveal 
deposition of proteoglycans and Col2a1, respectively. Larger 
images were taken using a 40x objective, while the insets 
(10x objective) show the overall appearance of the pellets. 
(B) LRF suppresses COMP protein expression during BMSC 
chondrogenesis. Pellet cultures of uninfected and LRF-infected 
BMSC were harvested at the indicated time. The protein levels 
of COMP, endogenous LRF or FLAG-tagged LRF (with slightly 
larger molecular weight), and GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) were determined by Western blot as 
described in the experimental procedures. These results were 
reproducible in 3 different BMSC donors.
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Furthermore, the total GAG contents in LRF-expressing pel-
lets were also reduced (Fig. 3B) at days 14 and 21. Taken 
together, the above results indicate that overexpression of 
LRF effectively blocks chondrogenesis of primary human 
BMSC, thus confirming previous findings in C3H10T1/2 
mouse cell line.8
Endogenous LRF Is Constitutively High in 
Proliferating Stem Cells but Remains Low in 
Adult Chondrocytes
To examine the regulation of LRF expression during chon-
drogenesis, we next determined the endogenous levels of 
LRF in undifferentiated stem cells and adult chondrocytes. 
Western analysis revealed that the endogenous LRF protein 
was readily detectable in primary human BMSC isolated 
from 2 different donors (Fig. 4A, lanes 1 and 2), and in the 
mouse mesenchymal stem cell line C3H10T1/2 (lane 3). In 
contrast, the levels of endogenous LRF were barely detect-
able in adult articular chondrocytes isolated from 2 donors 
(Fig. 4A, lanes 4 and 5), and in the immortalized human 
chondrocytic cell line C20/A4 (lane 6). These results indi-
cate that endogenous LRF expression is low in chondrocytes 
but high in BMSC, and in turn suggest that LRF expression 
might be suppressed during differentiation of BMSCs into 
chondrocytes. Indeed, when the levels of endogenous LRF 
were monitored during chondrogenesis of primary BMSCs 
in pellet culture, there was a time-dependent decrease of 
LRF protein (Fig. 4B). The decrease in LRF protein coin-
cided with a gradual increase in the expression of the chon-
drocyte-specific COMP protein, and hence correlated well 
with the progression of chondrogenesis. Collectively, these 
data are consistent with the model that LRF is an inhibitor 
of chondrogenesis, and therefore, LRF expression is sup-
pressed during chondrogenesis.
LRF Enhances Proliferation of BMSC
We next examined the effects of LRF expression on BMSC 
proliferation to gain insight into the mechanism of which 
LRF inhibits chondrogenesis. Since LRF is an oncogene 
that is required for maintaining normal cellular prolifera-
tion, we tested the effects of LRF overexpression on the 
growth rate of BMSC. LRF was overexpressed in BMSC 
through lentiviral transduction to ~5-fold the level of 
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Figure 3. Leukemia/lymphoma-related factor (LRF) reduces 
pellet culture size and inhibits glycoaminoglycan (GAG) 
production. (A) LRF reduces pellet size. The physical dimensions 
of various pellets were measured by a ruler. Each grid = 1 mm. 
(B) LRF inhibits GAG production. The total GAG contents 
in the pellets at various time points were determined by 
DMMB (dimethylmethylene blue) assays as described in the 
experimental procedures. Results with standard deviation were 
averages of 2 different donors.
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Figure 4. Expression of endogenous leukemia/lymphoma-
related factor (LRF) is constitutively high in undifferentiated 
human bone marrow–derived mesenchymal stem cells (BMSCs) 
and decreases during chondrogenesis. (A) Endogenous levels 
of LRF in primary human BMSC (passage 2-3) and articular 
chondrocytes (passage 0) from 2 different donors, and in 
C3H10T1/2 and C20/A4 cell lines were determined by 
Western blot. (B) LRF expression is down-regulated during 
chondrogenesis. The protein levels of cartilage oligomeric matrix 
protein (COMP) and LRF were determined at the indicated time 
during chondrogenesis of BMSC in pellet cultures.
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endogenous LRF (Fig. 5A). The proliferation rates of unin-
fected BMSCs, or BMSCs infected with GFP- or LRF-
expressing lentivirus were measured by mitochondrial 
dehydrogenase activity (Fig. 5B) and by counting the cell 
numbers (Fig. 5C) over a 6-day period. The results demon-
strated a similar growth rate increased in both uninfected 
and GFP-infected BMSCs. In contrast, LRF-infected 
BMSC showed significantly higher dehydrogenase activity 
and cell numbers that were apparent at day 4 and 6 (Fig. 5B 
and C). These results indicate that LRF enhances prolifera-
tion of BMSCs.
LRF Enhances Cell Cycle Progression in BMSC
It has been shown that LRF suppresses p19ARF transcrip-
tion, thus enhancing degradation of p53 that is important for 
regulating cell cycle arrest.3 This prompted us to investigate 
the effects of LRF overexpression on the cell cycle profile of 
BMSCs. Flow cytometry analysis revealed that uninfected 
and GFP-infected BMSCs demonstrated similar cell cycle 
profiles (representative cell cycle profiles from a single 
donor are shown in Fig. 6A-C). Data determined from three 
BMSC donors showed that on average, there were ~80% 
cells in G1 phase and ~10% cells in each of S and G2/M 
phase in uninfected and GFP-expressing cells (Fig. 6). 
However, compared with control cells, LRF-infected 
BMSCs showed a significant decrease in G1 population 
(~63%), and this is accompanied by a corresponding increase 
in the S phase (~27%; Fig. 6D). On the other hand, the popu-
lation of cells in the G2/M phase did not change significantly 
for all samples measured. Taken together, these data indicate 
that LRF overexpression increases the S1 population that are 
primed for mitosis, and correlates with the above results that 
LRF enhances cellular proliferation.
LRF Overexpression Reduces p53 Levels in 
BMSC Pellet Cultures
Apart from functioning as a tumor suppressor to induce 
cellular senescence, p53 is necessary for terminally 
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Figure 5. Leukemia/lymphoma-related factor (LRF) enhances human bone marrow–derived mesenchymal stem cells (BMSCs) 
proliferation. (A) Lentiviral-mediated overexpression of LRF in BMSC. The levels of endogenous and FLAG-tagged LRF in uninfected 
and LRF-infected BMSC were determined Western blot with anti-LRF antibody 5 days after infection. (B) LRF enhances proliferation 
of BMSC. The activities of mitochondrial dehydrogenase in uninfected BMSC or green fluorescent protein (GFP)-/LRF-infected BMSC 
at the indicated times were measured as described in the experimental procedures. Results with stand deviations were the averages of 
3 independent experiments (from 3 BMSC donors) with each data point performed in triplicate wells. (*P < 0.05). (C) LRF enhances 
growth rate of BMSC. Uninfected BMSC or GFP-/LRF-infected BMSC were grown in 12-well plates, and the number of cells were 
counted in a hemocytometer at the indicated times. day 0 was set at 4-day post-infection. Results are shown as percentage increase 
over the cell numbers at day 0, with standard deviations determined from 3 different BMSC donors (*P < 0.05).
Yik et al. 335
differentiating cells to establish a quiescent state.14,15 
Chondrocytes are enclosed within their own pericellular 
matrix with limited space for dividing, so entering a quies-
cent state is critical for maintaining the chondrocytic phe-
notype. We therefore examined the changes in the protein 
levels of p53 during chondrogenesis of BMSC in pellet 
cultures. The results showed that p53 level increased sig-
nificantly during chondrogenesis of normal BMSCs (Fig. 7, 
compared lanes 1 and 2). In contrast, there was a significant 
decrease in p53 level during chondrogenesis of BMSC 
overexpressing LRF (Fig. 7, compared lanes 3 and 4). 
These data indicate that high levels of LRF suppress p53 
expression in differentiating chondrocytes.
Discussion
Expression of LRF is detected in a variety of different cell 
types.6 Numerous studies have indicated that LRF may 
have diverse physiological functions during embryonic 
development and also in the regulation of tissue homeosta-
sis and senescence.3,16-19 To our knowledge, this is the first 
study to investigate the role of LRF in chondrogenesis of 
Figure 6. Leukemia/lymphoma-related factor (LRF) facilitates cell cycle progression of human bone marrow–derived mesenchymal 
stem cells (BMSCs). The cell cycle profiles of uninfected BMSC, and green fluorescent protein (GFP)- or LRF-infected BMSC were 
determined by flow cytometry as described in the experimental procedures. At least 10 x 103 cells were counted in each sample. The 
representative cell cycle profiles were shown. The percentages of cells in the G1, S, and G2/M phases were the averages with standard 
deviations determined from 3 different donors using FlowJo software (*P < 0.05).
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primary human BMSCs. Our findings reveal a difference 
between the expression of LRF in undifferentiated BMSC 
(high LRF) and in articular chondrocytes (low LRF). 
Moreover, expression of endogenous LRF is suppressed 
during differentiation of BMSC into chondrocytes, suggest-
ing that LRF is a natural inhibitor of chondrogenesis that is 
downregulated during this process. This is supported by the 
results that chondrogenesis is inhibited when the expression 
of LRF in BMSC (Figs. 1 and 2) and chondrocytes (not 
shown) is artificially maintained at high levels.
Our current study demonstrates that LRF enhances the 
proliferation of primary human BMSCs by facilitating cell 
cycle progression. This is in agreement with our previous 
finding that LRF depletion severely suppresses the prolif-
eration of chondrosarcoma cell lines.7 High LRF expression 
is known to enhance p53 degradation and prevent 
p53-mediated cell cycle arrest.3 As a result, excessive LRF 
leads to uncontrolled cellular proliferation and this may 
contribute to the malignancy of chondrosarcoma7 and other 
human cancers.4 On the other hand, mouse embryonic 
fibroblasts deficient in LRF have reduced growth and 
increased senescence rates,3,5 indicating that normal level of 
LRF is required to maintain continuous cellular prolifera-
tion. We postulate that this aspect of LRF function is espe-
cially important in maintaining the self-renewal capacity of 
stem cells and preventing their premature senescence.
Our previous data in a mouse mesenchymal stem cell 
line8 and our present study in primary human BMSCs both 
confirm that ectopic overexpression of LRF effectively 
inhibits chondrogenesis. However, the precise mechanism 
remains unknown. Since a high level of LRF is detected in 
the developing mouse limb bud prior to overt chondrogen-
esis,6 we postulate that LRF may function to promote pro-
liferation of chondro-progenitor cells, while preventing 
their premature differentiation into chondrocytes. Adult 
chondrocytes in the cartilage rarely divide and they last for 
the entire life span of an organism. As chondrocytes are sur-
rounded by pericellular and extracellular matrix in the car-
tilage, there is very limited space for proliferation. As a 
result, high levels of LRF that promote cell division would 
seem detrimental to the chondrocyte phenotype.
We therefore propose a model to describe the function of 
LRF in chondrogenesis (Fig. 8). In this model, high level of 
LRF in BMSCs mainly functions to prevent senescence by 
promoting their self-renewal and proliferation capacity. 
While a decrease in LRF expression during chondrogenesis 
allows the accumulation of p53 and facilitates the transition 
of maturing chondrocytes into a quiescent state as they are 
enclosed within the cartilage matrix. This hypothesis is sup-
ported by the findings that the tumor suppressor p53 is 
important for establishing cellular quiescence in terminally 
differentiated cells,14,15 and therefore, low level of LRF in 
chondrocytes may in turn enhance p53’s function in this 
respect, as evident by our data in Figure 6.
In summary, we demonstrated in this study the function 
of LRF in stimulating BMSC proliferation and in inhibiting 
chondrogenesis. Our data suggest that by modulating the 
activity of LRF, one might be able to increase the 
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Figure 7. Leukemia/lymphoma-related factor (LRF) 
overexpression suppresses p53 levels during human 
bone marrow–derived mesenchymal stem cells (BMSCs) 
chondrogenesis. (A) p53 levels during chondrogenesis of 
BMSC. The protein levels of cartilage oligomeric matrix protein 
(COMP), LRF (endogenous and FLAG-tagged), p53, and GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase) in day 0 and day 
14 pellet cultures of uninfected BMSC, or BMSC overexpressing 
LRF, are determined by Western blot. (B) The expression of 
p53 detected by Western blots were quantified by densitometry 
and normalized to GAPDH levels. The levels of p53 from 
day 0 pellet cultures were set to 100%. Results with standard 
deviation were the average of experiments using BMSC from 2 
different donors.
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proliferation and self-renewal capacity of stem cell and 
affects their chondrogenic differentiation.
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